Titan Medical Inc. (TSE:TMD) – Roth Capital issued their FY2016 earnings estimates for shares of Titan Medical in a research report issued on Tuesday. Roth Capital analyst C. Lewis expects that the brokerage will post earnings per share of ($0.25) for the year. Roth Capital currently has a “Buy” rating on the stock. Roth Capital also issued estimates for Titan Medical’s Q4 2016 earnings at ($0.05) EPS, Q1 2017 earnings at ($0.07) EPS, Q2 2017 earnings at ($0.07) EPS, Q3 2017 earnings at ($0.08) EPS, Q4 2017 earnings at ($0.08) EPS, FY2017 earnings at ($0.27) EPS and FY2018 earnings at ($0.31) EPS.

“Titan Medical Inc. (TMD) Expected to Earn FY2016 Earnings of ($0.25) Per Share” was first reported by Daily Political and is the property of of Daily Political. If you are accessing this piece on another website, it was copied illegally and reposted in violation of US and international trademark and copyright law. The correct version of this piece can be viewed at http://www.dailypolitical.com/2017/02/16/titan-medical-inc-tmd-expected-to-earn-fy2016-earnings-of-0-25-per-share.html.

Titan Medical (TSE:TMD) opened at 0.49 on Thursday. Titan Medical has a 12-month low of $0.31 and a 12-month high of $1.43. The company’s market cap is $81.59 million. The company’s 50 day moving average is $0.50 and its 200 day moving average is $0.52.

“Titan Medical Inc. (TMD) Expected to Earn FY2016 Earnings of ($0.25) Per Share” was first reported by Daily Political and is the property of of Daily Political. If you are accessing this piece on another website, it was copied illegally and reposted in violation of US and international trademark and copyright law. The correct version of this piece can be viewed at http://www.dailypolitical.com/2017/02/16/titan-medical-inc-tmd-expected-to-earn-fy2016-earnings-of-0-25-per-share.html.

Titan Medical Company Profile

Titan Medical Inc is a Canada-based company engaged in developing robotic surgical system for use in connection with minimally invasive surgery (MIS) (surgery without large incisions). The Company is developing the SPORT (Single Port Orifice Robotic Technology) Surgical System, a single-port/single-incision robotic surgical system to provide tele-operation (remote surgery) capabilities.

Receive News & Ratings for Titan Medical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Titan Medical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.